Patents by Inventor Radoslav KOPRNA

Radoslav KOPRNA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230192697
    Abstract: Object of the invention are mesylates of heterocyclic cytokinins of general formula I: (I) wherein R is selected from the group comprising C3-C15 cycloalkyl, furfuryl, allyl, 4-hydroxy-3-methylbut-2-en-1-yl, 3-methylbut-2-en-1-yl, 4-hydroxy-3-methylbutyl, 4-hydroxy-1,3-dimethylbut-2-en-1-yl, 4-hydroxy-1,3-dimethylbutyl, benzyl, wherein the cycloalkyl, allyl, benzyl and furfuryl may be unsubstituted or optionally substituted with 1 to 3 substituents selected from the group comprising hydroxy, halogen, methyl, hydroxymethyl and methoxy, and salts, solvates and addition salts therof.
    Type: Application
    Filed: August 22, 2020
    Publication date: June 22, 2023
    Inventors: Dardan KLOS, Lucie PLIHALOVA, Marek ZATLOUKAL, Karel DOLEZAL, Radoslav KOPRNA, Miroslav STRNAD, Jan WALLA, Jarmila BALONOVA
  • Patent number: 10662194
    Abstract: The invention relates to substituted 6-anilino-9-heterocyclylpurine derivatives of formula I wherein R denotes one to five substituents independently selected from the group hydrogen, halogen, hydroxy, amino, alkyloxy and alkyl group, R2 is selected from the group comprising amino, halogen, hydroxy, thio, and alkylthio group, Cyc is five- or six-membered heterocyclic ring containing one oxygen atom. The derivatives are useful for inhibition of plant stress.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: May 26, 2020
    Assignee: UNIVERZITA PALACKEHO V OLOMOUCI
    Inventors: Marek Zatloukal, Lucie Plihalova, Jana Klaskova, Lukas Spichal, Radoslav Koprna, Karel Dolezal, Miroslav Strnad
  • Patent number: 9993002
    Abstract: Substituted 1,2,3-thiadiazol-5yl-urea derivatives, their use as anti-senescence and anti-stress factors of plant cells, organs and the whole plant, and preparations containing these derivatives.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: June 12, 2018
    Assignees: USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I., UNIVERZITA PALACKEHO V OLOMOUCI
    Inventors: Jaroslav Nisler, Marek Zatloukal, Lukas Spichal, Radoslav Koprna, Karel Dolezal, Miroslav Strnad
  • Publication number: 20170342072
    Abstract: The invention relates to substituted 6-anilino-9-heterocyclylpurine derivatives of formula I wherein R denotes one to five substituents independently selected from the group hydrogen, halogen, hydroxy, amino, alkyloxy and alkyl group, R2 is selected from the group comprising amino, halogen, hydroxy, thio, and alkylthio group, Cyc is five- or six-membered heterocyclic ring containing one oxygen atom. The derivatives are useful for inhibition of plant stress.
    Type: Application
    Filed: December 9, 2015
    Publication date: November 30, 2017
    Applicant: UNIVERZITA PALACKEHO V OLOMOUCI
    Inventors: Marek ZATLOUKAL, Lucie PLIHALOVA, Jana KLASKOVA, Lukas SPICHAL, Radoslav KOPRNA, Karel DOLEZAL, Miroslav STRNAD
  • Publication number: 20170280721
    Abstract: Substituted 1,2,3-thiadiazol-5yl-urea derivatives, their use as anti-senescence and anti-stress factors of plant cells, organs and the whole plant, and preparations containing these derivatives.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 5, 2017
    Applicant: USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I.
    Inventors: Jaroslav NISLER, Marek ZATLOUKAL, Lukas SPICHAL, Radoslav KOPRNA, Karel DOLEZAL, Miroslav STRNAD